Non-Standardized Food Allergenic Extract [EPC]

Non-Standardized Food Allergenic Extract [EPC] was reported 79896 times

Drugs of the Non-Standardized Food Allergenic Extract [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 155 0.5116
1 BODY TINEA 58 0.1036
2 FEMALE GENITAL TRACT FISTULA 172 0.1006
3 SERONEGATIVE ARTHRITIS 109 0.0951
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 60 0.0898
5 LUPUS VULGARIS 107 0.0849
6 MULTIPLE DRUG THERAPY 57 0.0756
7 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
8 RADICULOPATHY 182 0.0690
9 CHRONIC SINUSITIS 252 0.0671
10 SEDATION COMPLICATION 161 0.0630
11 PROCTITIS 168 0.0599
12 RETINITIS 102 0.0590
13 MACULAR DEGENERATION 695 0.0581
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 97 0.0468
15 CREATININE RENAL CLEARANCE DECREASED 170 0.0424
16 DISLOCATION OF VERTEBRA 94 0.0412
17 INHIBITORY DRUG INTERACTION 65 0.0410
18 DEEP VEIN THROMBOSIS POSTOPERATIVE 77 0.0384
19 MUSCLE CRAMP 59 0.0332
20 SWOLLEN JOINT COUNT INCREASED 103 0.0323
21 INFECTION SUSCEPTIBILITY INCREASED 65 0.0297
22 BONE EROSION 100 0.0282
23 HAEMORRHAGIC ANAEMIA 123 0.0280
24 NEPHROGENIC ANAEMIA 127 0.0274
25 WALKING AID USER 172 0.0261
26 ANOSMIA 362 0.0250
27 VAGINAL DISCHARGE 248 0.0245
28 RHEUMATIC FEVER 105 0.0235
29 HYPERPARATHYROIDISM SECONDARY 57 0.0227
30 BLOOD CALCIUM DECREASED 255 0.0227
31 EXOSTOSIS 204 0.0223
32 PARAESTHESIA ORAL 312 0.0216
33 JOINT DISLOCATION 226 0.0214
34 RENAL FUNCTION TEST ABNORMAL 93 0.0200
35 RHEUMATOID FACTOR POSITIVE 115 0.0199
36 HYPERCHOLESTEROLAEMIA 191 0.0198
37 BLOOD TESTOSTERONE DECREASED 135 0.0197
38 WOUND INFECTION 214 0.0195
39 JOINT RANGE OF MOTION DECREASED 255 0.0190
40 WOUND COMPLICATION 64 0.0186
41 REBOUND ACID HYPERSECRETION 56 0.0185
42 ORAL CANDIDIASIS 240 0.0182
43 GLUCOSE TOLERANCE IMPAIRED 106 0.0179
44 INJECTION SITE PAPULE 81 0.0177
45 PRE-EXISTING CONDITION IMPROVED 109 0.0174
46 VITAMIN D DECREASED 145 0.0169
47 LOWER GASTROINTESTINAL HAEMORRHAGE 125 0.0169
48 SCIATICA 266 0.0167
49 MUSCLE INJURY 138 0.0166
50 BODY HEIGHT DECREASED 177 0.0165
51 SPONDYLITIS 58 0.0159
52 SPINAL COLUMN STENOSIS 75 0.0159
53 SPINAL FUSION SURGERY 64 0.0158
54 TRIGGER FINGER 64 0.0156
55 SPINAL OSTEOARTHRITIS 137 0.0156
56 GRIP STRENGTH DECREASED 137 0.0156
57 ORTHOSTATIC HYPOTENSION 270 0.0155
58 FREQUENT BOWEL MOVEMENTS 418 0.0155
59 HYPERKERATOSIS 84 0.0152
60 COLITIS MICROSCOPIC 72 0.0152
61 SKIN ATROPHY 87 0.0151
62 LUPUS-LIKE SYNDROME 137 0.0151
63 PARANASAL SINUS DISCOMFORT 57 0.0150
64 TENDON PAIN 114 0.0150
65 AGEUSIA 375 0.0150
66 JOINT STIFFNESS 391 0.0149
67 INCREASED UPPER AIRWAY SECRETION 76 0.0148
68 IRRITABLE BOWEL SYNDROME 315 0.0147
69 DIFFICULTY IN WALKING 50 0.0145
70 NASAL DISCOMFORT 115 0.0145
71 DECREASED INTEREST 84 0.0142
72 HELICOBACTER INFECTION 144 0.0140
73 POOR QUALITY SLEEP 291 0.0135
74 INTERVERTEBRAL DISC DEGENERATION 125 0.0135
75 HYPERLIPIDAEMIA 161 0.0135
76 BALANCE DISORDER 1140 0.0132
77 SKIN ABRASION 61 0.0129
78 OSTEOARTHRITIS 547 0.0129
79 PRESCRIBED UNDERDOSE 257 0.0129
80 MENISCUS INJURY 79 0.0128
81 RED BLOOD CELL SEDIMENTATION RATE INCREASED 142 0.0128
82 RHINITIS ALLERGIC 57 0.0128
83 PERICARDITIS 215 0.0128
84 ENDOMETRIOSIS 61 0.0128
85 SEASONAL ALLERGY 181 0.0128
86 INITIAL INSOMNIA 131 0.0128
87 FOOT DEFORMITY 141 0.0127
88 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 82 0.0126
89 INCREASED TENDENCY TO BRUISE 116 0.0126
90 PAROSMIA 95 0.0126
91 BLOOD CALCIUM INCREASED 110 0.0125
92 HYPERAESTHESIA 103 0.0125
93 CHAPPED LIPS 54 0.0124
94 THERAPY CESSATION 638 0.0124
95 DUODENAL ULCER PERFORATION 92 0.0124
96 PRODUCT SUBSTITUTION ISSUE 709 0.0123
97 ONYCHOMYCOSIS 54 0.0123
98 FAECAL INCONTINENCE 59 0.0123
99 FIBROMYALGIA 298 0.0122
100 ROSACEA 57 0.0122
101 SINUS CONGESTION 164 0.0121
102 AUTOIMMUNE DISORDER 118 0.0121
103 MUSCLE FATIGUE 51 0.0120
104 GINGIVAL SWELLING 53 0.0120
105 VITAMIN D DEFICIENCY 117 0.0120
106 TENDERNESS 125 0.0120
107 ROTATOR CUFF SYNDROME 154 0.0120
108 SINUS HEADACHE 71 0.0119
109 HIP ARTHROPLASTY 183 0.0119
110 UPPER-AIRWAY COUGH SYNDROME 98 0.0119
111 MULTIPLE ALLERGIES 93 0.0119
112 DIVERTICULUM 84 0.0118
113 TENDON DISORDER 77 0.0118
114 PERONEAL NERVE PALSY 67 0.0118
115 IMPAIRED WORK ABILITY 252 0.0118
116 MICTURITION URGENCY 134 0.0117
117 RECTAL HAEMORRHAGE 502 0.0117
118 FULL BLOOD COUNT DECREASED 235 0.0117
119 SQUAMOUS CELL CARCINOMA OF SKIN 70 0.0116
120 ATELECTASIS 112 0.0116
121 UPPER RESPIRATORY TRACT INFECTION 535 0.0116
122 DEFAECATION URGENCY 81 0.0115
123 LOCAL SWELLING 201 0.0115
124 WOUND 322 0.0115
125 PROCEDURAL PAIN 319 0.0115
126 SINUSITIS 1178 0.0115
127 ABDOMINAL TENDERNESS 57 0.0115
128 NAIL DISORDER 100 0.0114
129 BLOOD MAGNESIUM DECREASED 98 0.0113
130 IMPAIRED HEALING 372 0.0113
131 TENDONITIS 175 0.0113
132 PHARYNGOLARYNGEAL PAIN 60 0.0113
133 ANORECTAL DISCOMFORT 60 0.0113
134 INFUSION SITE SWELLING 71 0.0113
135 MOBILITY DECREASED 810 0.0113
136 LACERATION 106 0.0113
137 MIDDLE INSOMNIA 210 0.0112
138 RENAL CYST 89 0.0112
139 PEMPHIGUS 140 0.0112
140 MUSCULOSKELETAL PAIN 586 0.0112
141 ABDOMINAL HERNIA 51 0.0112
142 GLOSSODYNIA 248 0.0111
143 RESTLESS LEGS SYNDROME 201 0.0110
144 BENIGN PROSTATIC HYPERPLASIA 57 0.0110
145 SKIN WARM 64 0.0110
146 BLADDER DISORDER 109 0.0110
147 DYSPEPSIA 1079 0.0110
148 HIATUS HERNIA 141 0.0109
149 SMALL INTESTINAL OBSTRUCTION 134 0.0109
150 THERAPY CHANGE 107 0.0109
151 PERIPHERAL VASCULAR DISORDER 56 0.0109
152 OSTEOPOROSIS 447 0.0109
153 SINUS DISORDER 215 0.0108
154 SKIN TIGHTNESS 51 0.0108
155 SCAB 123 0.0108
156 CONTUSION 1034 0.0107
157 PROCTALGIA 69 0.0107
158 BLOOD ALBUMIN DECREASED 85 0.0107
159 TRICUSPID VALVE INCOMPETENCE 85 0.0107
160 SLEEP APNOEA SYNDROME 204 0.0107
161 DIVERTICULITIS 296 0.0107
162 FLATULENCE 605 0.0107
163 SOMNAMBULISM 70 0.0107
164 URINE OUTPUT DECREASED 93 0.0106
165 COLITIS 402 0.0106
166 SYNOVITIS 191 0.0106
167 APPLICATION SITE BURN 52 0.0105
168 MUSCLE TIGHTNESS 171 0.0105
169 BLOOD POTASSIUM DECREASED 317 0.0105
170 CONSTIPATION 2283 0.0105
171 PRODUCT FORMULATION ISSUE 69 0.0104
172 BLOOD IRON DECREASED 123 0.0104
173 CLOSTRIDIUM DIFFICILE INFECTION 226 0.0103
174 TYPE 2 DIABETES MELLITUS 348 0.0103
175 FOLLICULITIS 108 0.0103
176 EAR PAIN 200 0.0103
177 LARGE INTESTINE POLYP 71 0.0102
178 HAEMATOCRIT DECREASED 203 0.0102
179 COGNITIVE DISORDER 478 0.0102
180 HOSPICE CARE 101 0.0102
181 OSTEOPENIA 155 0.0102
182 FAILURE TO THRIVE 53 0.0102
183 URINE ODOUR ABNORMAL 60 0.0102
184 GAIT INABILITY 341 0.0102
185 MUSCULOSKELETAL CHEST PAIN 157 0.0101
186 QUALITY OF LIFE DECREASED 136 0.0101
187 GROIN PAIN 89 0.0101
188 IMPAIRED DRIVING ABILITY 115 0.0101
189 DIZZINESS POSTURAL 98 0.0101
190 NERVE COMPRESSION 93 0.0101
191 MUSCLE STRAIN 87 0.0100
192 ACTIVITIES OF DAILY LIVING IMPAIRED 199 0.0100
193 NOCTURIA 122 0.0100
194 MUSCLE ATROPHY 127 0.0100
195 BRONCHITIS 742 0.0100
196 CARPAL TUNNEL SYNDROME 140 0.0100
197 INJECTION SITE NODULE 110 0.0100
198 BLOOD CHOLESTEROL INCREASED 464 0.0099
199 MUSCULAR WEAKNESS 1130 0.0099
200 GINGIVAL PAIN 79 0.0099
201 BREAST CANCER STAGE III 64 0.0099
202 VITREOUS FLOATERS 97 0.0099
203 TOOTH ABSCESS 100 0.0098
204 CLOSTRIDIUM DIFFICILE COLITIS 104 0.0098
205 CELLULITIS 494 0.0098
206 PULMONARY FIBROSIS 188 0.0098
207 EAR INFECTION 260 0.0098
208 BURSITIS 118 0.0097
209 THERMAL BURN 69 0.0097
210 COAGULOPATHY 162 0.0097
211 BONE DISORDER 177 0.0097
212 LYMPHOEDEMA 67 0.0097
213 DRY MOUTH 784 0.0097
214 HYPOAESTHESIA 1445 0.0096
215 DRY THROAT 98 0.0096
216 TENDON RUPTURE 119 0.0096
217 LOWER LIMB FRACTURE 185 0.0096
218 GASTROOESOPHAGEAL REFLUX DISEASE 774 0.0096
219 PRESCRIBED OVERDOSE 186 0.0096
220 KNEE ARTHROPLASTY 202 0.0096
221 GAIT DISTURBANCE 1834 0.0096
222 PELVIC PAIN 174 0.0096
223 TINNITUS 440 0.0096
224 HAEMATOCHEZIA 528 0.0096
225 EYE INFECTION 108 0.0096
226 TOOTH INFECTION 126 0.0095
227 EAR DISCOMFORT 98 0.0095
228 NEURALGIA 232 0.0095
229 NERVE INJURY 106 0.0095
230 BURNING SENSATION 667 0.0095
231 ARTERIOSCLEROSIS CORONARY ARTERY 63 0.0095
232 TOOTHACHE 172 0.0095
233 TEMPERATURE INTOLERANCE 98 0.0095
234 ENERGY INCREASED 56 0.0095
235 FLUSHING 962 0.0095
236 LIVER FUNCTION TEST INCREASED 203 0.0094
237 NECK PAIN 528 0.0094
238 POLLAKIURIA 394 0.0094
239 END STAGE RENAL DISEASE 172 0.0094
240 CHOLECYSTITIS CHRONIC 63 0.0094
241 NEUROPATHY PERIPHERAL 893 0.0094
242 DERMATITIS CONTACT 107 0.0094
243 INFUSION SITE ERYTHEMA 79 0.0094
244 HOT FLUSH 706 0.0094
245 SCOLIOSIS 58 0.0094
246 PSORIATIC ARTHROPATHY 380 0.0094
247 PANIC ATTACK 341 0.0093
248 VENTRICULAR EXTRASYSTOLES 97 0.0093
249 PHOTOPSIA 59 0.0093
250 DYSSTASIA 272 0.0093
251 JAW DISORDER 51 0.0093
252 NIGHT SWEATS 300 0.0093
253 ONYCHOCLASIS 64 0.0093
254 MENSTRUAL DISORDER 77 0.0093
255 DYSURIA 342 0.0093
256 FEELING JITTERY 177 0.0093
257 BOWEL MOVEMENT IRREGULARITY 71 0.0093
258 MUSCLE SPASMS 1699 0.0092
259 HYPOAESTHESIA ORAL 139 0.0092
260 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 66 0.0092
261 GASTROENTERITIS VIRAL 166 0.0092
262 SPINAL COMPRESSION FRACTURE 76 0.0092
263 HYPOPHAGIA 235 0.0092
264 SKIN INFECTION 103 0.0092
265 ARTHROPOD BITE 68 0.0092
266 ORAL PAIN 205 0.0091
267 DYSMENORRHOEA 121 0.0091
268 CARDIAC FLUTTER 59 0.0091
269 INSOMNIA 2427 0.0091
270 WEIGHT DECREASED 2534 0.0091
271 PAIN IN JAW 257 0.0091
272 BLOOD URINE PRESENT 172 0.0091
273 MUSCULOSKELETAL STIFFNESS 792 0.0090
274 DENTAL CARIES 100 0.0090
275 TOOTH DISORDER 201 0.0090
276 EXERCISE TOLERANCE DECREASED 52 0.0090
277 INCONTINENCE 95 0.0090
278 PHOTOPHOBIA 169 0.0090
279 SEDATION 235 0.0090
280 HAEMORRHOIDS 175 0.0090
281 DECUBITUS ULCER 73 0.0089
282 FAECES SOFT 65 0.0089
283 GLAUCOMA 172 0.0089
284 PARAESTHESIA 1402 0.0089
285 URINARY INCONTINENCE 264 0.0089
286 ABNORMAL FAECES 73 0.0089
287 GASTROINTESTINAL PAIN 98 0.0089
288 SENSATION OF FOREIGN BODY 75 0.0089
289 HYPOVOLAEMIA 52 0.0089
290 OESOPHAGITIS 97 0.0089
291 PRURITUS GENERALISED 192 0.0089
292 JOINT EFFUSION 61 0.0088
293 MOUTH SWELLING 51 0.0088
294 RED BLOOD CELL COUNT DECREASED 252 0.0088
295 RASH MACULAR 308 0.0088
296 POST-TRAUMATIC STRESS DISORDER 59 0.0088
297 LIGAMENT SPRAIN 87 0.0088
298 RASH PAPULAR 197 0.0088
299 ANAL INCONTINENCE 79 0.0088
300 FEELING HOT 537 0.0088
301 HYPERSOMNIA 251 0.0087
302 UTERINE LEIOMYOMA 64 0.0087
303 HAIR TEXTURE ABNORMAL 117 0.0087
304 INTERVERTEBRAL DISC PROTRUSION 191 0.0087
305 NASAL CONGESTION 513 0.0087
306 DYSGEUSIA 648 0.0087
307 BREAST PAIN 93 0.0087
308 MENORRHAGIA 171 0.0087
309 UPPER GASTROINTESTINAL HAEMORRHAGE 146 0.0087
310 FALL 2888 0.0087
311 PERIPHERAL COLDNESS 119 0.0087
312 SENSORY DISTURBANCE 139 0.0087
313 CONCUSSION 67 0.0086
314 SCREAMING 55 0.0086
315 SCRATCH 91 0.0086
316 SECRETION DISCHARGE 108 0.0086
317 FEELING COLD 240 0.0086
318 TOOTH FRACTURE 95 0.0086
319 NASAL DRYNESS 54 0.0086
320 INFUSION SITE PAIN 111 0.0086
321 ARTHRITIS 677 0.0086
322 COLITIS ULCERATIVE 384 0.0086
323 PANIC REACTION 62 0.0086
324 HYDRONEPHROSIS 64 0.0085
325 BACK PAIN 1985 0.0085
326 PAIN OF SKIN 230 0.0085
327 CHRONIC KIDNEY DISEASE 649 0.0085
328 MUSCULOSKELETAL DISCOMFORT 147 0.0085
329 DYSPHONIA 499 0.0085
330 CORONARY ARTERY OCCLUSION 117 0.0085
331 SCAR 146 0.0085
332 ERUCTATION 165 0.0085
333 DYSPNOEA EXERTIONAL 321 0.0085
334 PERIPHERAL SWELLING 1312 0.0085
335 CYSTITIS 271 0.0085
336 PRODUCTIVE COUGH 406 0.0085
337 CATARACT 506 0.0085
338 PURPURA 75 0.0085
339 HAND FRACTURE 60 0.0085
340 ABASIA 209 0.0085
341 BLOOD COUNT ABNORMAL 128 0.0084
342 OEDEMA PERIPHERAL 1029 0.0084
343 AMNESIA 549 0.0084
344 WRIST FRACTURE 101 0.0084
345 BACK DISORDER 137 0.0084
346 CHROMATURIA 190 0.0084
347 RHINORRHOEA 544 0.0084
348 LIMB DISCOMFORT 260 0.0084
349 ATRIAL FLUTTER 67 0.0084
350 LOW DENSITY LIPOPROTEIN INCREASED 65 0.0084
351 FAECES DISCOLOURED 182 0.0084
352 PAIN IN EXTREMITY 2473 0.0084
353 SQUAMOUS CELL CARCINOMA 79 0.0084
354 THERAPEUTIC RESPONSE UNEXPECTED 376 0.0084
355 STOMATITIS 508 0.0084
356 IMPAIRED QUALITY OF LIFE 120 0.0083
357 FORMICATION 58 0.0083
358 RASH PRURITIC 451 0.0083
359 SKIN DISORDER 277 0.0083
360 GALLBLADDER DISORDER 148 0.0083
361 BACK INJURY 90 0.0083
362 OEDEMA 448 0.0083
363 PULMONARY MASS 123 0.0082
364 HEAD DISCOMFORT 146 0.0082
365 DEHYDRATION 1099 0.0082
366 INFUSION RELATED REACTION 546 0.0082
367 MUSCLE SPASTICITY 101 0.0082
368 MITRAL VALVE INCOMPETENCE 93 0.0082
369 CRYING 298 0.0082
370 BREAST MASS 55 0.0082
371 WHEEZING 485 0.0082
372 FATIGUE 6364 0.0082
373 ANOREXIA 105 0.0081
374 RESPIRATORY TRACT CONGESTION 129 0.0081
375 EYE PAIN 458 0.0081
376 VIRAL INFECTION 270 0.0081
377 MUSCLE TWITCHING 187 0.0081
378 ABDOMINAL DISTENSION 846 0.0081
379 BREAST TENDERNESS 61 0.0081
380 HEART RATE IRREGULAR 183 0.0081
381 HAIR GROWTH ABNORMAL 56 0.0081
382 HAND DEFORMITY 106 0.0081
383 RIB FRACTURE 166 0.0081
384 FEELING ABNORMAL 1929 0.0080
385 NODULE 105 0.0080
386 MOOD SWINGS 256 0.0080
387 MUSCLE DISORDER 65 0.0080
388 URINARY TRACT INFECTION 1368 0.0080
389 IRON DEFICIENCY ANAEMIA 74 0.0080
390 TONGUE DISORDER 58 0.0080
391 DEPRESSION 1822 0.0080
392 MEMORY IMPAIRMENT 1100 0.0080
393 FLANK PAIN 75 0.0080
394 OROPHARYNGEAL PAIN 740 0.0080
395 ORAL HERPES 156 0.0080
396 ROAD TRAFFIC ACCIDENT 334 0.0080
397 CYST 99 0.0080
398 ASTHENIA 2998 0.0080
399 SKIN DISCOLOURATION 366 0.0080
400 LETHARGY 458 0.0080
401 BLISTER 447 0.0080
402 RASH GENERALISED 206 0.0079
403 FURUNCLE 63 0.0079
404 MYALGIA 1351 0.0079
405 FEELING DRUNK 59 0.0079
406 WEIGHT FLUCTUATION 83 0.0079
407 LUNG INFILTRATION 70 0.0079
408 DIARRHOEA HAEMORRHAGIC 74 0.0079
409 GOUT 142 0.0079
410 JOINT INJURY 169 0.0079
411 PALPITATIONS 926 0.0079
412 BLOOD SODIUM DECREASED 149 0.0079
413 APPLICATION SITE PAIN 174 0.0079
414 SKIN REACTION 111 0.0079
415 ACUTE RESPIRATORY FAILURE 151 0.0078
416 STAPHYLOCOCCAL INFECTION 258 0.0078
417 RENAL FAILURE CHRONIC 60 0.0078
418 DEEP VEIN THROMBOSIS 507 0.0078
419 DIZZINESS 3885 0.0078
420 ABDOMINAL PAIN 1811 0.0078
421 HEAD INJURY 245 0.0077
422 MENTAL STATUS CHANGES 215 0.0077
423 RENAL PAIN 82 0.0077
424 ECCHYMOSIS 53 0.0077
425 HEPATIC CIRRHOSIS 145 0.0077
426 DISTURBANCE IN ATTENTION 416 0.0077
427 ORAL DISCOMFORT 107 0.0077
428 BLOOD TRIGLYCERIDES INCREASED 136 0.0077
429 FLUID OVERLOAD 112 0.0077
430 INJECTION SITE BRUISING 613 0.0077
431 THIRST 137 0.0077
432 INJECTION SITE HAEMORRHAGE 612 0.0077
433 THYROID DISORDER 118 0.0076
434 OBSTRUCTIVE AIRWAYS DISORDER 85 0.0076
435 CHEST PAIN 1415 0.0076
436 MENTAL IMPAIRMENT 185 0.0076
437 BASAL CELL CARCINOMA 119 0.0076
438 CHILLS 893 0.0076
439 NERVOUSNESS 398 0.0076
440 BEDRIDDEN 100 0.0076
441 RETCHING 162 0.0076
442 JOINT SWELLING 917 0.0076
443 DIARRHOEA 4901 0.0076
444 DEPRESSED LEVEL OF CONSCIOUSNESS 300 0.0076
445 MIGRAINE 723 0.0076
446 LABORATORY TEST ABNORMAL 223 0.0075
447 HICCUPS 62 0.0075
448 ARTERIOSCLEROSIS 71 0.0075
449 LOCALISED INFECTION 182 0.0075
450 ARTHRALGIA 3129 0.0075
451 HYPOXIA 265 0.0075
452 NASOPHARYNGITIS 1387 0.0075
453 NEPHROLITHIASIS 345 0.0075
454 EPISTAXIS 562 0.0075
455 ANGER 254 0.0075
456 THROAT IRRITATION 337 0.0075
457 ABNORMAL DREAMS 207 0.0075
458 DECREASED APPETITE 1741 0.0075
459 ANKLE FRACTURE 116 0.0075
460 CONFUSIONAL STATE 1208 0.0075
461 FUNGAL INFECTION 249 0.0075
462 HEPATIC ENZYME INCREASED 509 0.0075
463 BLOOD UREA INCREASED 125 0.0075
464 GASTROINTESTINAL HAEMORRHAGE 623 0.0074
465 VAGINAL HAEMORRHAGE 323 0.0074
466 IMMUNE SYSTEM DISORDER 98 0.0074
467 PULMONARY CONGESTION 98 0.0074
468 INFLUENZA LIKE ILLNESS 611 0.0074
469 BLOOD PRESSURE INCREASED 1133 0.0074
470 BONE PAIN 434 0.0074
471 PRESYNCOPE 180 0.0074
472 LIP DRY 67 0.0074
473 SLEEP DISORDER 520 0.0074
474 ATRIAL FIBRILLATION 717 0.0074
475 WHITE BLOOD CELL COUNT DECREASED 797 0.0073
476 PULMONARY HYPERTENSION 153 0.0073
477 HIP FRACTURE 236 0.0073
478 ABDOMINAL DISCOMFORT 1230 0.0073
479 ANXIETY 2085 0.0073
480 CHOLELITHIASIS 240 0.0073
481 NIGHTMARE 253 0.0073
482 WEIGHT INCREASED 1635 0.0073
483 HEART RATE INCREASED 723 0.0073
484 OSTEOMYELITIS 132 0.0073
485 HEADACHE 4569 0.0073
486 PLEURAL EFFUSION 443 0.0073
487 PRODUCT DOSE OMISSION 475 0.0073
488 UNEVALUABLE EVENT 550 0.0073
489 PHOTOSENSITIVITY REACTION 120 0.0073
490 MOTOR DYSFUNCTION 74 0.0073
491 POST PROCEDURAL INFECTION 59 0.0072
492 SLUGGISHNESS 74 0.0072
493 CHEST DISCOMFORT 742 0.0072
494 APHONIA 101 0.0072
495 HAEMOGLOBIN DECREASED 743 0.0072
496 ARTHROPATHY 401 0.0072
497 COLD SWEAT 127 0.0072
498 C-REACTIVE PROTEIN INCREASED 262 0.0072
499 TREMOR 1195 0.0072
500 VISION BLURRED 988 0.0072
501 FOOT FRACTURE 136 0.0072
502 SKIN LACERATION 78 0.0072
503 MASS 100 0.0071
504 HYPERCALCAEMIA 88 0.0071
505 MOVEMENT DISORDER 228 0.0071
506 COORDINATION ABNORMAL 99 0.0071
507 INTERNATIONAL NORMALISED RATIO INCREASED 202 0.0071
508 THINKING ABNORMAL 132 0.0071
509 NAUSEA 5602 0.0071
510 ANAEMIA 1349 0.0071
511 RHINITIS 57 0.0071
512 LYMPHADENOPATHY 250 0.0071
513 FLUID RETENTION 359 0.0071
514 VERTIGO 429 0.0070
515 HERPES ZOSTER 404 0.0070
516 UPPER LIMB FRACTURE 140 0.0070
517 GASTROINTESTINAL INFLAMMATION 55 0.0070
518 PARANOIA 121 0.0070
519 SKIN HAEMORRHAGE 104 0.0070
520 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 337 0.0070
521 ERYTHEMA 1441 0.0070
522 DIPLOPIA 182 0.0070
523 RASH PUSTULAR 51 0.0070
524 INJURY 492 0.0070
525 ABDOMINAL PAIN UPPER 1440 0.0070
526 COUGH 1960 0.0070
527 INJECTION SITE PRURITUS 468 0.0070
528 SPUTUM DISCOLOURED 66 0.0070
529 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 495 0.0070
530 ORAL DISORDER 51 0.0070
531 SNEEZING 156 0.0069
532 GASTRIC ULCER 132 0.0069
533 FACIAL PAIN 62 0.0069
534 SWELLING FACE 452 0.0069
535 EMPHYSEMA 70 0.0069
536 PELVIC FRACTURE 54 0.0069
537 DRY EYE 345 0.0069
538 HAIR COLOUR CHANGES 86 0.0069
539 HYPOKINESIA 100 0.0069
540 GINGIVAL BLEEDING 94 0.0069
541 RESPIRATORY RATE INCREASED 61 0.0069
542 CANDIDA INFECTION 116 0.0069
543 FOOD ALLERGY 53 0.0069
544 INJECTION SITE INDURATION 89 0.0069
545 APATHY 100 0.0068
546 FISTULA 77 0.0068
547 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 355 0.0068
548 METRORRHAGIA 116 0.0068
549 EYE SWELLING 253 0.0068
550 PNEUMONIA 2199 0.0068
551 BLOOD POTASSIUM INCREASED 110 0.0068
552 SPINAL DISORDER 64 0.0068
553 DRUG EFFECT DECREASED 364 0.0068
554 TASTE DISORDER 137 0.0067
555 LACRIMATION INCREASED 204 0.0067
556 MENSTRUATION DELAYED 73 0.0067
557 DRUG DOSE OMISSION 1113 0.0067
558 MADAROSIS 78 0.0067
559 ALOPECIA 1319 0.0067
560 ACNE 509 0.0067
561 TROPONIN INCREASED 51 0.0067
562 SKIN ULCER 173 0.0067
563 WRONG TECHNIQUE IN DRUG USAGE PROCESS 243 0.0067
564 HYPOMAGNESAEMIA 93 0.0067
565 CHOLECYSTECTOMY 76 0.0066
566 PNEUMONIA ASPIRATION 166 0.0066
567 LIVER INJURY 163 0.0066
568 HEART RATE DECREASED 233 0.0066
569 SWELLING 619 0.0066
570 DRY SKIN 882 0.0066
571 OBSESSIVE-COMPULSIVE DISORDER 53 0.0066
572 SKIN FISSURES 129 0.0066
573 PSORIASIS 861 0.0066
574 ASPIRATION 72 0.0066
575 APPLICATION SITE ERYTHEMA 172 0.0066
576 HAIR DISORDER 54 0.0065
577 DRUG EFFECT INCOMPLETE 238 0.0065
578 RENAL FAILURE ACUTE 278 0.0065
579 PAIN 4022 0.0065
580 BLOOD PRESSURE FLUCTUATION 157 0.0065
581 PLASMA CELL MYELOMA 255 0.0065
582 HERNIA 126 0.0065
583 FEAR 175 0.0065
584 RASH ERYTHEMATOUS 311 0.0065
585 UROSEPSIS 60 0.0065
586 INJECTION SITE ERYTHEMA 806 0.0065
587 HYPERTENSION 1375 0.0065
588 HYPERHIDROSIS 835 0.0065
589 CARDIAC MURMUR 56 0.0065
590 GASTROINTESTINAL INFECTION 58 0.0065
591 SENSORY LOSS 52 0.0065
592 LIP SWELLING 215 0.0064
593 SKIN EXFOLIATION 544 0.0064
594 EYE HAEMORRHAGE 86 0.0064
595 MALNUTRITION 72 0.0064
596 EJECTION FRACTION DECREASED 100 0.0064
597 ERECTILE DYSFUNCTION 165 0.0064
598 CARDIOMEGALY 79 0.0064
599 KIDNEY INFECTION 126 0.0064
600 PSEUDOMONAS INFECTION 55 0.0064
601 OVARIAN CYST 64 0.0064
602 VISUAL IMPAIRMENT 793 0.0064
603 DYSPNOEA 3621 0.0064
604 TRANSFUSION 67 0.0064
605 HUNGER 89 0.0064
606 GASTRITIS 168 0.0064
607 BACTERIAL INFECTION 119 0.0064
608 PNEUMOTHORAX 101 0.0064
609 BLOOD ALKALINE PHOSPHATASE INCREASED 158 0.0064
610 APHASIA 192 0.0064
611 BIPOLAR DISORDER 69 0.0063
612 SPEECH DISORDER 332 0.0063
613 HEPATIC STEATOSIS 118 0.0063
614 EYE DISORDER 208 0.0063
615 URINARY RETENTION 211 0.0063
616 INJECTION SITE WARMTH 130 0.0063
617 INJECTION SITE URTICARIA 155 0.0063
618 SINUS BRADYCARDIA 61 0.0063
619 PRURITUS 2423 0.0063
620 PYREXIA 2180 0.0063
621 PHARYNGITIS 78 0.0063
622 BLOOD PRESSURE ABNORMAL 125 0.0063
623 THROAT TIGHTNESS 170 0.0063
624 PHARYNGITIS STREPTOCOCCAL 68 0.0063
625 PULMONARY EMBOLISM 597 0.0063
626 URTICARIA 1051 0.0063
627 INJECTION SITE PAIN 1914 0.0062
628 BACTERAEMIA 74 0.0062
629 HYPOTHYROIDISM 199 0.0062
630 BLOOD BILIRUBIN INCREASED 168 0.0062
631 RENAL TUBULAR NECROSIS 61 0.0062
632 SWOLLEN TONGUE 194 0.0062
633 HALLUCINATION 468 0.0062
634 DISORIENTATION 246 0.0062
635 MUSCULOSKELETAL DISORDER 118 0.0062
636 DELIRIUM 215 0.0062
637 GASTRIC DISORDER 212 0.0062
638 BODY TEMPERATURE INCREASED 126 0.0062
639 ASPARTATE AMINOTRANSFERASE INCREASED 328 0.0062
640 ABDOMINAL PAIN LOWER 156 0.0062
641 DISCOMFORT 376 0.0062
642 PLATELET COUNT DECREASED 656 0.0061
643 OCULAR DISCOMFORT 69 0.0061
644 SPINAL PAIN 72 0.0061
645 GENERALISED OEDEMA 76 0.0061
646 TRANSIENT ISCHAEMIC ATTACK 207 0.0061
647 DEPRESSED MOOD 324 0.0061
648 SKIN BURNING SENSATION 439 0.0061
649 LYMPHOCYTE COUNT DECREASED 108 0.0061
650 HALLUCINATION, VISUAL 129 0.0061
651 INTESTINAL OBSTRUCTION 230 0.0061
652 RETINAL DETACHMENT 56 0.0061
653 DISABILITY 120 0.0061
654 SPLENOMEGALY 71 0.0061
655 DELUSION 94 0.0060
656 IMMUNODEFICIENCY 90 0.0060
657 HAEMOPTYSIS 168 0.0060
658 MOOD ALTERED 164 0.0060
659 SOMNOLENCE 1210 0.0060
660 DYSPHAGIA 570 0.0060
661 LOSS OF LIBIDO 54 0.0060
662 RASH 2614 0.0060
663 RESPIRATORY TRACT INFECTION 156 0.0060
664 SPINAL FRACTURE 120 0.0060
665 BLOOD THYROID STIMULATING HORMONE INCREASED 55 0.0060
666 INJECTION SITE MASS 221 0.0060
667 IRRITABILITY 359 0.0060
668 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 424 0.0060
669 WHITE BLOOD CELL COUNT INCREASED 228 0.0059
670 DECREASED ACTIVITY 64 0.0059
671 HYPERSENSITIVITY 1099 0.0059
672 INCORRECT DRUG ADMINISTRATION DURATION 166 0.0059
673 CENTRAL NERVOUS SYSTEM LESION 81 0.0059
674 PULMONARY THROMBOSIS 64 0.0059
675 INTERNAL HAEMORRHAGE 67 0.0059
676 NEUTROPHIL COUNT INCREASED 60 0.0059
677 VOMITING 2753 0.0058
678 PHARYNGEAL OEDEMA 90 0.0058
679 POST PROCEDURAL HAEMORRHAGE 68 0.0058
680 POST PROCEDURAL COMPLICATION 112 0.0058
681 MULTIPLE SCLEROSIS RELAPSE 398 0.0058
682 DRUG ADMINISTERED AT INAPPROPRIATE SITE 61 0.0058
683 ULCER 92 0.0058
684 BRAIN OEDEMA 73 0.0058
685 MULTIPLE SCLEROSIS 276 0.0058
686 SYNCOPE 576 0.0058
687 INFLAMMATION 297 0.0057
688 VISUAL ACUITY REDUCED 191 0.0057
689 CORONARY ARTERY DISEASE 174 0.0057
690 LUNG INFECTION 89 0.0057
691 DERMATITIS 120 0.0057
692 SKIN LESION 157 0.0057
693 FEEDING DISORDER 116 0.0057
694 EYELID PTOSIS 58 0.0057
695 RENAL FAILURE 756 0.0057
696 SYSTEMIC LUPUS ERYTHEMATOSUS 202 0.0057
697 CARDIAC FAILURE CONGESTIVE 456 0.0057
698 LIMB INJURY 154 0.0057
699 PROSTATIC SPECIFIC ANTIGEN INCREASED 78 0.0057
700 SUBDURAL HAEMATOMA 81 0.0057
701 WITHDRAWAL SYNDROME 237 0.0056
702 PERICARDIAL EFFUSION 130 0.0056
703 CARDIOMYOPATHY 83 0.0056
704 ELECTROLYTE IMBALANCE 65 0.0056
705 PARALYSIS 80 0.0056
706 TACHYCARDIA 494 0.0056
707 HAEMATOMA 144 0.0056
708 INFECTION 804 0.0055
709 BLOOD PRESSURE DECREASED 369 0.0055
710 SKIN IRRITATION 254 0.0055
711 HAEMATURIA 189 0.0055
712 INFLUENZA 615 0.0055
713 BODY TEMPERATURE DECREASED 54 0.0055
714 MALAISE 2403 0.0055
715 BLINDNESS UNILATERAL 77 0.0055
716 ALANINE AMINOTRANSFERASE INCREASED 335 0.0055
717 SUPRAVENTRICULAR TACHYCARDIA 52 0.0054
718 METASTASES TO BONE 89 0.0054
719 THROMBOSIS 436 0.0054
720 COELIAC DISEASE 53 0.0054
721 EATING DISORDER 115 0.0054
722 HEPATOMEGALY 53 0.0054
723 ATAXIA 64 0.0054
724 EYE DISCHARGE 56 0.0054
725 BLOOD PRESSURE SYSTOLIC INCREASED 105 0.0054
726 INSURANCE ISSUE 82 0.0054
727 INJECTION SITE DISCOLOURATION 67 0.0054
728 PRODUCT ODOUR ABNORMAL 56 0.0053
729 LIVER FUNCTION TEST ABNORMAL 155 0.0053
730 RHEUMATOID ARTHRITIS 605 0.0053
731 INTRAOCULAR PRESSURE INCREASED 68 0.0053
732 PULMONARY ARTERIAL HYPERTENSION 77 0.0053
733 DYSARTHRIA 200 0.0053
734 MALIGNANT MELANOMA 71 0.0053
735 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 90 0.0053
736 SEPSIS 591 0.0053
737 CHOLECYSTITIS 63 0.0053
738 HYPOTENSION 1060 0.0053
739 DEMENTIA 147 0.0053
740 BRONCHOSPASM 75 0.0053
741 ACUTE KIDNEY INJURY 804 0.0052
742 LEUKOCYTOSIS 95 0.0052
743 UVEITIS 71 0.0052
744 TOOTH EXTRACTION 65 0.0052
745 RESTLESSNESS 191 0.0052
746 SUICIDAL IDEATION 477 0.0052
747 ABSCESS 83 0.0052
748 INJECTION SITE EXTRAVASATION 64 0.0052
749 INCREASED APPETITE 99 0.0052
750 OXYGEN SATURATION DECREASED 290 0.0052
751 INJECTION SITE RASH 158 0.0051
752 DEAFNESS 134 0.0051
753 OCULAR HYPERAEMIA 242 0.0051
754 INJECTION SITE SWELLING 389 0.0051
755 HYPOKALAEMIA 234 0.0051
756 APPLICATION SITE PRURITUS 115 0.0051
757 BLOOD GLUCOSE DECREASED 243 0.0051
758 DYSKINESIA 205 0.0050
759 CONDITION AGGRAVATED 1528 0.0050
760 THERAPY NON-RESPONDER 225 0.0050
761 NO THERAPEUTIC RESPONSE 61 0.0050
762 PULMONARY OEDEMA 224 0.0050
763 GASTROINTESTINAL DISORDER 448 0.0050
764 EYE IRRITATION 287 0.0050
765 CHOKING 97 0.0050
766 LOSS OF CONSCIOUSNESS 637 0.0050
767 HYPOACUSIS 214 0.0050
768 HYPONATRAEMIA 280 0.0050
769 PSYCHOMOTOR HYPERACTIVITY 82 0.0049
770 FEMUR FRACTURE 153 0.0049
771 GASTROENTERITIS 72 0.0049
772 HAEMATEMESIS 125 0.0049
773 ADVERSE DRUG REACTION 442 0.0049
774 IMPAIRED GASTRIC EMPTYING 67 0.0049
775 BLOOD TEST ABNORMAL 69 0.0049
776 BLOOD CREATININE INCREASED 320 0.0049
777 OBESITY 78 0.0049
778 PETECHIAE 51 0.0049
779 EMOTIONAL DISORDER 150 0.0049
780 NEUTROPHIL COUNT DECREASED 198 0.0049
781 ASTHMA 548 0.0048
782 DRUG-INDUCED LIVER INJURY 152 0.0048
783 UNRESPONSIVE TO STIMULI 125 0.0048
784 CARDIAC DISORDER 452 0.0048
785 INJECTION SITE REACTION 331 0.0048
786 PRODUCT QUALITY ISSUE 653 0.0048
787 RENAL DISORDER 224 0.0048
788 BONE DENSITY DECREASED 150 0.0048
789 AGITATION 351 0.0048
790 METASTASES TO LIVER 84 0.0048
791 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 111 0.0048
792 APPLICATION SITE RASH 65 0.0047
793 SINUS TACHYCARDIA 67 0.0047
794 INTENTIONAL PRODUCT MISUSE 412 0.0047
795 MENSTRUATION IRREGULAR 126 0.0047
796 HEMIPARESIS 79 0.0047
797 DRUG INTOLERANCE 450 0.0047
798 BLOOD GLUCOSE FLUCTUATION 51 0.0046
799 METASTASES TO CENTRAL NERVOUS SYSTEM 60 0.0046
800 SKIN CANCER 100 0.0046
801 JAUNDICE 124 0.0046
802 ACCIDENT 55 0.0046
803 PLATELET COUNT INCREASED 60 0.0046
804 LOWER RESPIRATORY TRACT INFECTION 209 0.0046
805 HYPERKALAEMIA 161 0.0046
806 EYE PRURITUS 154 0.0046
807 ABNORMAL BEHAVIOUR 181 0.0046
808 HALLUCINATION, AUDITORY 72 0.0045
809 PNEUMONITIS 122 0.0045
810 ANGINA PECTORIS 128 0.0045
811 DRUG ADMINISTRATION ERROR 137 0.0045
812 HYPERGLYCAEMIA 162 0.0044
813 PRODUCT USE COMPLAINT 70 0.0044
814 MANIA 73 0.0044
815 DEVICE RELATED INFECTION 68 0.0044
816 LUNG DISORDER 215 0.0044
817 ASCITES 128 0.0043
818 TACHYPNOEA 59 0.0043
819 BRAIN FOG 68 0.0043
820 DISEASE PROGRESSION 506 0.0043
821 ENCEPHALOPATHY 105 0.0043
822 BLOOD GLUCOSE INCREASED 802 0.0043
823 PANCYTOPENIA 237 0.0042
824 PHARMACEUTICAL PRODUCT COMPLAINT 110 0.0042
825 DIALYSIS 60 0.0042
826 COLON CANCER 63 0.0042
827 MOUTH ULCERATION 89 0.0042
828 DRUG INEFFECTIVE 5556 0.0042
829 INTENTIONAL PRODUCT USE ISSUE 369 0.0042
830 MENTAL DISORDER 183 0.0042
831 COMPLICATION ASSOCIATED WITH DEVICE 61 0.0042
832 GLYCOSYLATED HAEMOGLOBIN INCREASED 106 0.0042
833 CONVULSION 240 0.0042
834 APPLICATION SITE IRRITATION 52 0.0042
835 OSTEONECROSIS OF JAW 103 0.0042
836 HYPERTHYROIDISM 60 0.0041
837 ANHEDONIA 108 0.0041
838 ARRHYTHMIA 194 0.0041
839 ECONOMIC PROBLEM 62 0.0041
840 DRUG INTERACTION 643 0.0040
841 PALLOR 110 0.0040
842 RENAL INJURY 120 0.0040
843 PANCREATITIS 212 0.0040
844 SEIZURE 463 0.0040
845 DEVICE MALFUNCTION 280 0.0040
846 RESPIRATORY DISORDER 119 0.0040
847 RESPIRATORY FAILURE 290 0.0040
848 DERMATITIS ALLERGIC 50 0.0040
849 FEBRILE NEUTROPENIA 263 0.0040
850 SEPTIC SHOCK 172 0.0039
851 LIVER DISORDER 175 0.0039
852 HYPOGLYCAEMIA 191 0.0039
853 TOOTH LOSS 81 0.0039
854 DIABETES MELLITUS 297 0.0039
855 TUBULOINTERSTITIAL NEPHRITIS 73 0.0039
856 DRUG TOXICITY 53 0.0039
857 HAEMORRHAGE INTRACRANIAL 58 0.0039
858 ACUTE MYOCARDIAL INFARCTION 114 0.0039
859 MELAENA 85 0.0039
860 DEVICE DISLOCATION 167 0.0038
861 PRODUCT TASTE ABNORMAL 52 0.0038
862 BLOOD GLUCOSE ABNORMAL 69 0.0037
863 CEREBRAL HAEMORRHAGE 133 0.0037
864 PRODUCT USE ISSUE 698 0.0037
865 MULTI-ORGAN FAILURE 64 0.0037
866 GENERAL PHYSICAL HEALTH DETERIORATION 428 0.0037
867 PANCREATITIS ACUTE 83 0.0037
868 CEREBROVASCULAR ACCIDENT 623 0.0037
869 AGGRESSION 184 0.0037
870 ACUTE RESPIRATORY DISTRESS SYNDROME 65 0.0037
871 BLOOD LACTATE DEHYDROGENASE INCREASED 58 0.0037
872 RESPIRATORY DISTRESS 101 0.0037
873 SURGERY 214 0.0036
874 MUCOSAL INFLAMMATION 95 0.0036
875 DEVICE ISSUE 323 0.0036
876 RASH MACULO-PAPULAR 80 0.0036
877 BRADYCARDIA 190 0.0036
878 UNDERDOSE 261 0.0036
879 PRODUCT PHYSICAL ISSUE 72 0.0036
880 MEDICATION ERROR 198 0.0036
881 CONJUNCTIVITIS 66 0.0036
882 HAEMORRHAGE 370 0.0035
883 THROMBOCYTOPENIA 392 0.0035
884 CONTRAINDICATED PRODUCT ADMINISTERED 106 0.0035
885 THERAPY INTERRUPTED 250 0.0035
886 NERVOUS SYSTEM DISORDER 109 0.0035
887 SEROTONIN SYNDROME 67 0.0035
888 TOXICITY TO VARIOUS AGENTS 584 0.0035
889 PSYCHOTIC DISORDER 102 0.0035
890 RENAL IMPAIRMENT 289 0.0034
891 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 187 0.0034
892 CIRCULATORY COLLAPSE 58 0.0034
893 DRUG DISPENSING ERROR 52 0.0034
894 DEVICE FAILURE 51 0.0033
895 STEVENS-JOHNSON SYNDROME 74 0.0033
896 GENERALISED TONIC-CLONIC SEIZURE 55 0.0033
897 LEUKOPENIA 166 0.0033
898 CYANOSIS 52 0.0033
899 LYMPHOMA 51 0.0033
900 INCORRECT DOSE ADMINISTERED 746 0.0033
901 DRUG LEVEL INCREASED 54 0.0033
902 INTENTIONAL DRUG MISUSE 68 0.0032
903 ECZEMA 170 0.0032
904 NEUTROPENIA 439 0.0032
905 MYOCARDIAL INFARCTION 552 0.0032
906 HEPATITIS 80 0.0031
907 THERAPEUTIC PRODUCT EFFECT DECREASED 140 0.0031
908 DRUG PRESCRIBING ERROR 60 0.0031
909 HYPOCALCAEMIA 59 0.0031
910 MALIGNANT NEOPLASM PROGRESSION 318 0.0031
911 PREGNANCY 62 0.0031
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 89 0.0031
913 VENTRICULAR TACHYCARDIA 51 0.0031
914 DRUG EXPOSURE DURING PREGNANCY 105 0.0031
915 FACE OEDEMA 52 0.0031
916 ANAPHYLACTIC REACTION 170 0.0031
917 TREATMENT NONCOMPLIANCE 168 0.0031
918 DIABETES MELLITUS INADEQUATE CONTROL 54 0.0030
919 METABOLIC ACIDOSIS 96 0.0030
920 NEOPLASM PROGRESSION 104 0.0030
921 OFF LABEL USE 2606 0.0030
922 CARDIO-RESPIRATORY ARREST 123 0.0029
923 DRUG ERUPTION 52 0.0029
924 ILL-DEFINED DISORDER 178 0.0029
925 NEEDLE ISSUE 84 0.0029
926 HOSPITALISATION 440 0.0029
927 EXPIRED PRODUCT ADMINISTERED 95 0.0029
928 EOSINOPHILIA 50 0.0029
929 CARDIAC ARREST 232 0.0028
930 INTENTIONAL DOSE OMISSION 80 0.0028
931 EXTRA DOSE ADMINISTERED 112 0.0028
932 ILLNESS 284 0.0028
933 HEPATIC FAILURE 83 0.0028
934 THERAPEUTIC RESPONSE DECREASED 166 0.0027
935 DEVICE EXPULSION 176 0.0027
936 ADVERSE EVENT 247 0.0027
937 COVID-19 470 0.0027
938 BLINDNESS 107 0.0026
939 RHABDOMYOLYSIS 109 0.0026
940 DIABETIC KETOACIDOSIS 62 0.0026
941 PRODUCT DOSE OMISSION IN ERROR 73 0.0026
942 RESPIRATORY ARREST 71 0.0026
943 CARDIAC FAILURE 206 0.0026
944 DISEASE RECURRENCE 122 0.0026
945 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 455 0.0025
946 ELECTROCARDIOGRAM QT PROLONGED 87 0.0024
947 OSTEONECROSIS 79 0.0024
948 EMOTIONAL DISTRESS 288 0.0024
949 DRUG WITHDRAWAL SYNDROME 206 0.0023
950 COMA 111 0.0023
951 PRODUCT COMPLAINT 59 0.0023
952 LUNG NEOPLASM MALIGNANT 95 0.0023
953 ANGIOEDEMA 102 0.0023
954 ACCIDENTAL OVERDOSE 84 0.0023
955 THERAPEUTIC RESPONSE SHORTENED 76 0.0023
956 CEREBRAL INFARCTION 55 0.0022
957 ABORTION SPONTANEOUS 90 0.0022
958 NEOPLASM MALIGNANT 147 0.0022
959 OVERDOSE 473 0.0022
960 PRODUCT ADHESION ISSUE 77 0.0022
961 TREATMENT FAILURE 178 0.0021
962 PRODUCT USE IN UNAPPROVED INDICATION 532 0.0021
963 LACTIC ACIDOSIS 68 0.0021
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 75 0.0021
965 EPILEPSY 62 0.0020
966 PRODUCT DOSE OMISSION ISSUE 596 0.0020
967 TARDIVE DYSKINESIA 57 0.0020
968 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68 0.0020
969 INTERSTITIAL LUNG DISEASE 96 0.0020
970 INCORRECT DOSE ADMINISTERED BY DEVICE 51 0.0019
971 PANCREATIC CARCINOMA 56 0.0019
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 392 0.0019
973 HEPATIC FUNCTION ABNORMAL 72 0.0019
974 BREAST CANCER 179 0.0019
975 DEATH 1649 0.0019
976 EXPOSURE DURING PREGNANCY 111 0.0018
977 COMPLETED SUICIDE 143 0.0017
978 DEVICE LEAKAGE 73 0.0017
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 75 0.0016
980 DRUG ABUSE 125 0.0015
981 DEVICE BREAKAGE 59 0.0015
982 SUICIDE ATTEMPT 85 0.0014
983 MATERNAL EXPOSURE DURING PREGNANCY 120 0.0013
984 PROSTATE CANCER 104 0.0013
985 DEVICE DIFFICULT TO USE 69 0.0010
986 DERMATITIS ATOPIC 52 0.0010
987 ACCIDENTAL EXPOSURE TO PRODUCT 99 0.0010
988 PRODUCT STORAGE ERROR 70 0.0008
989 INTENTIONAL OVERDOSE 51 0.0008
990 NO ADVERSE EVENT 135 0.0007
991 DRUG DEPENDENCE 110 0.0007
992 FOETAL EXPOSURE DURING PREGNANCY 52 0.0006